Apogee Therapeutics (NASDAQ:APGE) Sets New 12-Month Low on Disappointing Earnings
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $29.15 and last traded at $29.20, with a volume of 199917 shares trading hands. The stock had previously closed at $31.39. The company reported […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $29.15 and last traded at $29.20, with a volume of 199917 shares trading hands. The stock had previously closed at $31.39. The company reported […]
